FAU-Studie zeigt, dass Überarbeitung und Stress die häufigsten Gründe für Kündigungen sind, gefolgt von schlechten Aufstiegsmöglichkeiten.

Sie verstoße gegen verschiedene Nachhaltigkeitskriterien für die Entwicklung der FAU. Rainer Hartmann, Vorsitzender des BN Kreisgruppe Erlangen, erklärt auf Nachfrage unserer Redaktion ...

Ricardo Grieshaber-Bouyer, MD, PhD, MHBA, Professor of Clinical Systems Immunology and Head of the Clinical Trials Unit at FAU Erlangen-Nuremberg, and global Principal Investigator for the trial ...

According to InvestingPro data, the company maintains a strong financial position with more cash than debt and a healthy current ratio of 13.5. The trial will take place at leading research ...

Erlangen - Nach Nürnberg kommt die beliebte Supermarktkette „Go Asia“ nun auch nach Erlangen. Wann es soweit ist und worauf sich Freunde fernöstlicher Kulinarik freuen können. Die ...

The clinical trial for CLN-978 will initiate in Q2 2025 at FAU Erlangen-Nuremberg and Università Cattolica del Sacro Cuore. The clinical trial is led by Dr. Ricardo Grieshaber-Bouyer at FAU ...

Earlier this year, the Bavarian State Parliament approved €270 million ($283m) of funding to expand the North Bavarian High-Performance Computing Center (NHR@FAU) at the Friedrich-Alexander University ...

Professor of Clinical Systems Immunology and Head of the Clinical Trials Unit at FAU Erlangen-Nuremberg, and global Principal Investigator for this trial. “This unmet need underscores the importance ...

Using CAR-T therapies, Schett and his colleagues in Erlangen, Germany, have managed to put diseases like lupus into complete remission, effectively making what until now have been viewed as ...

Company-sponsored clinical trial will be initiated at FAU Erlangen-Nuremberg in Germany and Università Cattolica del Sacro Cuore, Rome in Q2 2025 CLN-978 is also being studied in the U.S., Europe, and ...